KRAS and colorectal carcinoma: Regarding CRC, in the latest AJCC 8th edition [209], published in 2016, particular emphasis has been given to MMR deficiency sustained by germline and somatic mutations or epigenetic changes, as well to RAS pathway mutations (i.e., KRAS, BRAF and NRAS).